Skip to main content

Search on the website

Jobs

Work at the Institut Jules Bordet Working at the Institut Jules Bordet Wishing to evolve in a medical environment with the aim of delivering quality work? Then we invite you to join a dynamic, multicultural and highly qualified team.Whether you are doctors, nurses, paramedics, administrative staff or skilled workers, the Institut offers a very wide variety of employment positions, often unexpected.The Institut Jules Bordet is regularly looking to employ enthusiastic and motivated professionals and support staff. ...

bordet new

A new building for the Institut Jules Bordet Exclusive images of the new Jules Bordet Institute! Watch the video and discover the major project for the new Jules Bordet Institute. Magnificent images of the construction work on the   80,000 m² dedicated exclusively to cancer are accompanied by explanations on how the project was conceived to combine excellence of patient care with optimal well-being for patients and care staff. ...

history bordet

History of the Institut Jules Bordet, a pioneer in cancer research Since it was founded in 1939, the Institut Bordet has always remained loyal to its pioneering role in the fight against cancer. With this complex disease, the lives of patients and caregivers do more than simply cross paths, they become entwined. Here are some of the key dates in the history of the Institut Bordet – an institution that is proud of its past but which always looks resolutely towards the future. Creation of the Institut Jules BordetToday, the Institut Bordet remains Belgium’s only integrated, monospecialist cancer hospital. The European Organisation for Research and Treatment of Cancer (EORTC) is established by Professor TagnonToday, the EORTC includes around 300 institutions which work together to develop the best possible therapeutic str...

breast cancers

Breast cancers “Our patients receive support at every level, including psychological support”   Dr Martine Piccart, Medical Oncologist and Scientific Director How we treat breast cancers In Belgium, one woman in eight will develop breast cancer over the course of her life. The Institut Jules Bordet treats around 700 women a year. Our multidisciplinary teams were pioneers in a number of diagnostic and therapeutic approaches to these cancers. ...

thorax cancers

Cancers of the lungs and thoracic cavity “The therapeutic strategy depends on the type of cancer, its extent and the patient’s general state of health.”  Dr Thierry Berghmans, Head of the Thoracic Oncology Clinic How we treat cancers of the lungs and thoracic cavity Thanks to extensive internal and external collaboration, the Institut Bordet is able to treat all cancers of the thoracic cavity, including lung cancer.Several types of cancer can develop in the thorax: small and large cell lung (or “bronchial”) cancer, pulmonary metastases originating in other primary tumours and rare tumours such as cancer of the thymus, mesothelioma, pleura, etc. ...

blood cancer

Blood cell cancers « Advances in research and treatment while supporting and listening to the patient: the keys to recovery and quality of life »   Dr Nathalie Meuleman, HEAD OF THE DEPARTMENT OF HAEMATOLOGY-ONCOLOGY at the Institut Jules Bordet. How we treat blood cell cancers The Institut Jules Bordet treats all haematological cancers, ie blood cell and lymphatic cancers. ...

prostate cancers

Prostate cancers “Our aim is to preserve the patient’s quality of life while treating the tumour as effectively as possible.”   Dr Alexandre Peltier, Urological surgeon How we treat the prostate cancers Prostate cancer is the most common cancer in men. The Institut Jules Bordet has the cutting-edge technology needed to detect and treat these tumours. ...

rare tumours

Rare tumours “The Institut Jules Bordet has long been recognised for its treatment of rare tumours”   Dr Ahmad Awada, Oncologist How we treat rare tumours Rare tumours account for around a quarter of the cancers treated at the Institut Jules Bordet. These cancers require very particular and multidisciplinary treatment. A tumour is described as rare when it affects fewer than 6 people in 100,000. It may appear in an organ or in tissue that is only very rarely affected by cancer (eg: the salivary glands, the penis, etc), or may be situated in an organ where cancer is relatively common but show cell characteristics that are different from those usually observed. ...

gynaecological cancers

Gynaecological cancers “ We provide support and assistance to our patients in every aspect of their illness ”      Dr Jean-Marie Nogaret, Surgeon and head of the Gynaeco-Mammary Surgery Clinic How we treat gynaecological cancers The term gynaecological cancer covers cancers of the endometrium, the ovaries, the cervix, the vulva and the vagina. These intimate cancers require multidisciplinary, personalised care and treatment. ...

bone cancers

Bone and soft tissue cancers “Physiotherapy after orthopaedic surgery must remain in expert hands and must be gentle and delicate.”  Dr Michael Gebhart, Coordinator of the Institut Jules Bordet Soft Tissue and Bone Tumour Multidisciplinary Oncology Team. How we treat bone and soft tissue cancers The medical team at the Institut Jules Bordet treats tumours that appear in the soft tissue (muscles, fat, nerves, blood vessels, etc), primary bone cancer in children (in close collaboration with HUDERF – the Hôpital Universitaire des Enfants Reine Fabiola) and in adults as well as bone metastases.  ...

head neck cancers

ENT cancers of the head and neck « Providing comprehensive care for the patient is important for our multidisciplinary team but equally important is providing it without delay ... »  Delphine Talmon, Oncological Care Coordinating Nurse (ICSO) How we treat ENT cancers of the head and neck Head and neck cancers include all tumours that develop in the upper aerodigestive tract and ENT (ear, nose and throat) system: tongue, cheek, palate, nose, sinuses, salivary glands, larynx, pharynx, etc. ...

thyroid cancer

Thyroid cancers “The therapeutic strategy depends largely on the risk of persistence or recurrence of the disease.”  Dr Giuseppe Costante, Endocrinologist and Head of Thyroid Cancer at the EURACAN Project. How we treat thyroid cancers The Institut Jules Bordet treats all types of thyroid cancer. The great majority can be cured but require correct assessment of the risk of recurrence and follow-up care for life. ...

digestive cancers

Digestive tract cancers “Combining several treatments increases the chance of a cure and reduces recurrence of digestive cancer.”    Dr Alain Hendlisz, Coordinator of the Digestive CMO, Institut Jules Bordet. How we treat digestive tract cancers All the digestive organs can be affected by cancer: the oesophagus, stomach, pancreas, gall bladder and bile ducts, the small intestine, large intestine (colon) … even the anal margin. Management of these tumours is always multidisciplinary.  ...

colorectal cancers

Cancers of the colon and rectum “Our philosophy is to care for patients while sparing them any pointless and difficult treatments.”   Dr Alain Hendlisz, Coordinator of the Digestive Tumour CMO, Institut Bordet How we treat cancers of the colon or rectum Colorectal cancers are among the most common forms of cancer. Significant advances have been made in improving the way they are treated. Treatment requires a multidisciplinary approach. ...

Anatomopathology

Anatomical pathology department Our role The Anatomical Pathology Department is responsible for analysing tumours sent to it by the Institut Jules Bordet, the CHU St-Pierre and the Ixelles and Molière IRIS SUD hospitals. It is a reference centre in various fields, including the diagnosis of breast, gynaecological, digestive, urogenital, pulmonary, soft tissue and head and neck cancers and lymp...

Urological cancers

Male urological and genital cancers “Our patients are supported by a team of medical and paramedical specialists.”      Dr Alexandre Peltier, UROLOGICAL SURGEON How we treat male urological and genital cancers Urogenital cancers are tumours that develop in the urinary or genital system. ...

neuroendocrine tumours

Neuroendocrine tumours “A neuroendocrine tumour is a particular kind of digestive cancer that requires very specific management.”  Dr Alain Hendlisz, Coordinator of the Digestive Tumour CMO, Institut Bordet. How we treat neuroendocrine tumours Although often situated in an organ of the digestive tract, neuroendocrine tumours behave differently from other digestive cancers and must often be treated in a specific way. ...

liver cancers

Liver cancers “A surgeon never takes the decision to operate on their own. The management of hepatic tumours is always multidisciplinary.”  Dr Vincent Donckier, Hepatobiliary surgeon and head of surgery, Institut Bordet. How we treat liver cancers There are 2 types of hepatic cancer: primary liver cancer and hepatic metastases originating from other primary tumours. Surgery is the major treatment for these cancers but it is limited by the need to conserve sufficient functional liver tissue. Other therapies may be combined with surgery. ...

brain tumours

Brain tumours « Neuro-Oncology is above all a multidisciplinary approach at the centre of which the quality of life of the patient is crucial »  Dr Philippe Martinive Clinic Director How we treat brain tumours The Institut Jules Bordet treats both primary brain cancers and brain metastases. Medical imaging plays a major role in this treatment because, in the brain, accurate definition of the tumour is crucial. ...